Parmjit Sohal did his MD from the University of Alberta, Edmonton and PhD in Biochemistry from the University of Saskatchewan, Saskatoon in Canada.. He has been a Family Physician and Medical Director of the Surrey Medical & Travel Clinic. He is a Clinical Professor in the Department of Family Practice at the University of British Columbia, Vancouver, Canada. He is a staff member at the Surrey Memorial Hospital. His main area of interest is prevention and management of diabetes in high risk ethnic populations particularly in South Asians. He was awarded 2014 Canada’s Family Physician of the Year Award for BC by the College of Family Physicians of Canada. He was also recently awarded 2014 Frederick Banting Award from the Canadian Diabetes Association.
Prevention and management of diabetes
Dr Ojo has a PhD in nutrition from the University of Greenwich, London, a post graduate diploma in diabetes from University of Surrey, Roehampton and a graduate certificate in Higher Education from University of Greenwich. Prior to these qualifications, Dr Ojo had his BSc and MSc in animal science from University of Ibadan, Nigeria. He has been a Senior Lecturer in Primary Care for nearly seven years and he teaches across a range of courses and programmes in the Faculty of Education and Health, University of Greenwich. His key interest and areas of expertise are diabetes and nutrition which form the focus of his research and teaching activities. Dr Ojo leads the school Diabetes Specialist Interest Group and co-ordinates the Diabetes Care and Management course for post registration nurses and Patient Pathways of Care for pre-registration participants. He supervises both undergraduate and postgraduate research students including PhD students. His research interests are reflected in his 35 publications in reputable journals and 12 conference presentations. His work is recognised both nationally and internationally and he has been a keynote speaker at the NNNG conference in Manchester, UK and Global Diabetes Conference and Medicare Expo, in Birmingham, UK. Dr Ojo is a reviewer for a range of journals and he sits on the Editorial Board on a number of International Journals.
Prevention and management of diabetes
Dr. Raju Panta has earned professional medical degrees of MBBS and MD (three year residency in Basic and Clinical Physiology), under merit?based full scholarships from the nationally and internationally accredited medical colleges in Nepal. He was awarded the “Certificate of Expertise in Electrophysiology” after completion of his doctorate thesis during his residency. His thoughtful ideas inspired him to accomplish research work on Diabetes Mellitus where he studied the electroencephalographic evidence of central neuropathy in type 2 diabetes mellitus patients before overt peripheral neuropathy. Dr. Panta has been working in Trinity School of Medicine, St. Vincent and the Grenadines, West Indies, since November 2013 and serving as an Assistant Professor and Course Director of Physiology. In Trinity, he also has served as a member of the core committees for curriculum development, faculty search, promotion, research, academic progress, admissions, and institutional self-study. He has proven record of excellence in teaching as evidenced by a number of “SGA awards” awarded by ‘Student Government Association’ in recognition of the best professor in Trinity. In addition, he has extensive experience of participation in conferences, workshops, and continuing medical educations (CMEs) as a presenter, organizer, demonstrator, and a trainer. His organizational memberships include the American Physiological Society (APS), International Association of Medical Science Educators (IAMSE), Association for Medical Education in Europe (AMEE), Physiological Society of Nepal (PSN), and Nepal Medical Council.
Diabetes & Endocrinology
Prof. Iraqi is a molecular geneticist and world leader in the area of dissecting complex traits including hosts susceptibility to infection and chronic diseases. His current research is focused on understanding diseases etiology and host susceptibility to infectious and chronic diseases including Type 2 Diabetes and cardiovascular diseases (CVD) associated with obesity, Klebsiella pneumonia, Aspergillus fumigatus, dental infection (Periodontitis), gut microbiota and mapping modifiers for colon cancer development. Furthermore, he has an ongoing project for identifying the host genetic factors influencing immune response cell lineages in peripheral blood in the Collaborative Cross (CC) mouse population, which can lead to better predict host response to different diseases, based on genetic makeup (predictive genetic approach). His research projects are important for better understanding the host susceptibility to variety of infectious and chronic diseases, which will serve a step towards improving our knowledge of specific and general pathways and network systems, which can lead to establish better disease prevention and control strategies. For studying these diseases, he uses the mouse model, especially the unique and powerful mouse resource population known as the Collaborative Cross (CC), for studying systems genetics; including of performing quantitative trait loci (QTL) mapping, assessing gene expression profiles by RNAseq using deep sequence technology, which will lead of identifying and cloning the genes underlying the QTL, and subsequently indentify the ortholoug genes in human. He has number of ongoing joint collaborations with European scientists from Germany, the Netherlands, Switzerland, France, Spain and UK to use the CC mice for studying host susceptibility to different infectious and chronic diseases. Prof. Iraqi studied for his BSc. (Biology), MSc. (Biochemistry) and PhD (Molecular Genetics) at the Hebrew University at Jerusalem. He worked as a Postdoctoral for two years at the Hospital for Sick Children at Toronto, Canada, and two more years at the USDA, ARS- East Lansing, MI, before joining the International Livestock Research Institute (ILRI), based in Nairobi, Kenya as Scientist. In 2007, he moved to his current position as professor and Chairman of the department of Clinical Microbiology and Immunology, at the Faculty of Medicine at Tel-Aviv University. He has more than 135 publications on per reviewed Journals, and more than 25 book chapters. His current H-Index is 27.
Genetics of host susceptibility to Type 2 Development
Dr. Mahir Jallo, Faculty in the Canadian Academy of Natural Health – Canada. He is a Clinical Professor of Medicine & Senior Consultant, Internal Medicine - Diabetes & Endocrinology in Gulf Medical University – UAE. Granted his MB,ChB from Mosul Medical College in IRAQ, his postgraduate Board Certification in Internal Medicine CABM from the Arab Board, his Fellowship of American College of Endocrinology FACE. He joined the JCI Accredited GMCHRC –Thumbay Hospital in 2004 establishing the Diabetes & Endocrinology care in the hospital. He was an Affiliated Faculty in the Department of Medicine, Mosul Medical College & Department of Clinical Pharmacy, Mosul College of Pharmacy – in IRAQ till 2004. In his record active participation & speaker invitation in many National & International conferences & CME programs. Organizer of the annual GMU Diabetes & Endocrinology Conference since 2012. Editor In Chief: Diabetes Digest from Iraq, Editorial Board Member & reviewer for many international Diabetes & Endocrinology journals, with many publications in medical periodicals and medical conferences abstract. Active Principle Investigator in many National & International Clinical studies. Member of many national & international medical societies & associations, AACE, EASD, ISPAD, ESE & European Atherosclerosis Society. Awarded twice A Special Honor & Award in recognition of the exemplary achievements in the field of Internal Medicine & Endocrinology and for the invaluable service to the community.
Prevention and management of diabetes
Dr. Oron (currently Professor Emeritus at the Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Israel) received his BSc in chemistry and his MSc and PhD in biochemistry from the Hebrew University in Jerusalem. He further trained in diabetes research at the University of Virginia in the laboratory of Prof. Joseph Larner and continued to study signal transduction pathways at Tel Aviv University, utilizing mainly the Xenopus oocyte system and electrophysiology and microscopic imaging techniques as read-outs. In the last twelve years Dr. Oron changed the focus of his research to studying the biology of diabetes and pancreatic adenocarcinoma. In the past he served as Department Chair and as a Head of the Office of International Academic Relations at Tel Aviv University. He has authored and co-authored more than 110 peer-reviewed publications in quality journals, including Nature, Science, PNAS, and J Physiol.